Tempest Therapeutics

NASDAQ: TPST
Develops small molecule therapeutics designed to effectively treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

San Francisco, CA

Initial Investment

2018
Develops small molecule therapeutics designed to effectively treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.

Tempest Therapeutics (Nasdaq: TPST) is a development-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways.